Dr. Freddy Rick Malpartida, MD

Dr. Malpartida practices at Fresenius Medical Care Plantation in Temple Terrace, Florida.

Dr. Malpartida's NPI, 1417391178, was assigned on April 24, 2013. Dr. Malpartida graduated from Cayetano Heredia University in 2011. Dr. Malpartida holds Florida license ME135387.

Dr. Malpartida's primary practice is Fresenius Medical Care Plantation, at 12662 Telecom Dr, Temple Terrace, FL 33637 in Hillsborough County. The practice phone is (954) 382-0151.

Dr. Malpartida's primary practice is Fresenius Medical Care Plantation in Temple Terrace, Florida. Dr. Malpartida is also affiliated with HCA Florida Westside Hospital. The medical group on file is Florida Kidney Physicians. Dmand AI also links Dr. Malpartida to 3 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malpartida practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Malpartida's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Malpartida is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Malpartida's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Malpartida treats.

CMS data shows 1,544 Medicare services from Dr. Malpartida across 11 procedure codes in 2024, for 424 Medicare patients. Medicare paid $103,809 for them.

CMS counts 424 Medicare patients who saw Dr. Malpartida in 2024. The largest group is 75 to 84, with 149 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 38% are also on Medicaid. Their average risk score is 4.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malpartida's median patient age at 74, with 50% women.

In 2024, Dr. Malpartida wrote 1,049 Medicare Part D claims for 194 patients. 76% of them were for generic drugs. CMS names the drug for 828 of them, across 26 drugs with 11 or more claims each, at $208,011 in total drug cost. In 2023, CMS named 540 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Malpartida for performance year 2024, reported individually. Dr. Malpartida accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Malpartida, published from 2017 to 2018. 2017 was the busiest year, with 3. The most frequent topics are Kidney Failure, Chronic and Renal Dialysis. Dr. Malpartida's most frequent co-authors are Abhilash Koratala, MD, Kawther Farouk Alquadan, MD and Mayanka Kamboj.

CMS Open Payments shows 88 general payments to Dr. Malpartida from 19 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 99% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $321.

Dr. Malpartida graduated from Cayetano Heredia University in 2011.

Dr. Malpartida is in network with 20 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.